The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as . The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023. Volume today is light. Singular Genomics Systems Inc 50-day moving average is $1.71. On average, they predict the company's stock price to reach $3.50 in the next twelve months. All rights reserved. Their OMIC share price forecasts range from $3.00 to $4.50. In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and . The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. **Green highlights the top performing ETF by % change in the past 100 days. Mar 02, 2023. Intentionally designed to alleviate challenges faced by researchers in the lab today, the G4 Sequencing Platform features advanced engineering and novel chemistry to deliver faster results, with more operational flexibility. Owning 46% shares,institutional owners seem interested in Singular Genomics Systems, Inc. (NASDAQ:OMIC), Eli Glezer Is The Founder of Singular Genomics Systems, Inc. (NASDAQ:OMIC) And They Just Picked Up 1.2% More Shares, A Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider increased their holdings by 16% last year, Singular Genomics Systems, Inc. (OMIC) Q3 2022 Earnings Call Transcript, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Apple To $220? All rights reserved. Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. USD. . This data feed is available via Nasdaq Data Link APIs; to learn more about subscribing, visitNasdaq Data Link's products page. Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. One share of OMIC stock can currently be purchased for approximately $1.08. Operating expenses for 2022 totaled $93.5 million compared to $61.3 million in the prior year period. Support +1 (442) 742-2737 support@singulargenomics.com. Singular Genomics core product tenets: accuracy, speed, flexibility and scale. Singular Genomics undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. 3 equities research analysts have issued 12 month target prices for Singular Genomics Systems' stock. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. Singular Genomics Systems Inc 52 week high is $5.21 as of April 18, 2023. Stock prices may also move more quickly in this environment. About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. Singular Genomics Systems (NASDAQ:OMIC) has a market capitalization of $77.70 million and generates $760,000.00 in revenue each year. Singular Genomics Systems stock was originally listed at a price of $25.72 in May 27, 2021. It's fairly readable and I recommend taking a look if that . Stay Connected The company issued 8,500,000 shares at $20.00-$22.00 per share. Add to Watchlist 1.03-0.07 (-6.36%) Apr 12, 2023, 2:52 PM EDT - Market open. ET by Tomi Kilgore. The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The data displayed in the quote bar updates every 3 seconds; allowing you to monitor prices in real-time. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and. Net loss for the fourth quarter of 2022 was$21.1 million, or a loss of $0.29 per common share, comparedto $19.8 million, or a loss of $0.27 per common share, in the fourth quarter of 2021. Operating expenses for the fourth quarter of 2022 totaled$22.5 million, compared to $19.7 million for the fourth quarter of 2021. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. . The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Singular Genomics Systems Inc (OMIC) stock is trading at $1.17 as of 1:47 PM on Monday, Apr 10, a loss of -$0.11, or -8.59% from the previous closing price of $1.28. Active, Closed, Last funding round type (e.g. })}); 2022 Singular Genomics Systems, Inc. All rights reserved. Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Commodities. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Singular Genomics Systems, Inc. Market Cap $92M Today's Change (3.91%) $0.05 Current Price $1.33 Price as of March 16, 2023, 4:00 p.m. The year-over-year increase in total operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap, and the costs associated with being a public company. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) What is Singular Genomics Systems' stock symbol? Singular Genomics first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the G4 Integrated Solution. Singular Genomics Systems Inc 50-day moving average is $1.75. Raising the bar with industry-leading run times across applications. Measures how much net income or profit is generated as a percentage of revenue. GlobeNewswire. Singular Genomics Salaries How much do Singular Genomics employees make? Since then, OMIC stock has decreased by 46.3% and is now trading at $1.08. How many employees does Singular Genomics Systems have? Find the latest Singular Genomics Systems, Inc. (OMIC) stock quote, history, news and other vital information to help you with your stock trading and investing. May-26-21 11:56PM. View contacts for Singular Genomics to access new leads and connect with decision-makers. Investor Contact Matt Clawson +949-370-8500 ir@singulargenomics.com. See what's happening in the market right now with MarketBeat's real-time news feed. Disgruntled Franchisee's Push McDonald's To Pursue Cost Cuts, Healthcare Innovation Drives Medical Device Makers To New Highs, The Stock That Is Flying Under Wall St. Radar, Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 Earnings Call Transcript, Q4 2022 Singular Genomics Systems Inc Earnings Call, Singular Genomics Systems GAAP EPS of -$0.29 beats by $0.15, revenue of $0.77M beats by $0.04M, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT. Can Garrett Motion Turbocharge A Short Squeeze? Singular Genomics Systems, Inc. (OMIC) Q2 2022 Earnings Call Transcript, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, One Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider upped their stake by 16% in the previous year, Singular Genomics in pact with TwinStrand Biosciences for next gen sequencing, view top-rated stocks among Wall Street analysts, 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. It was a year in which we achieved important milestones, overcame challenges, and ultimately ended on a strong note with five G4 systems in market. Initial Registration Statement for Employee Benefit Plan . Thebidis the highest amount that a buyer is currently willing to pay, whereas the askis the lowest Singular Genomics Systems Inc P/B ratio is 0.2981. System throughput depends on sequencing application and flow cell. We are at AACR 2023! Represents the company's profit divided by the outstanding shares of its common stock. Revenue for the full year of 2022 was $765 thousand. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Singular Genomics is pushing sequencing further to bring fast, powerful and flexible tools for research and medicine. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section. Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Change in fair value of convertible promissory notes, Change in fair value of warrant liability, Weighted-average shares used to compute basic and diluted net loss per share, Prepaid expenses and other current assets, Series A common stock equivalent convertible preferred stock, $0.0001 par value; 7,000 shares authorized, 2,500 and no shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively, Common stock, $0.0001 par value; 400,000,000 shares authorized, 71,854,688 and 72,438,742 shares outstanding at December 31, 2022 and December 31, 2021, respectively, Total liabilities and stockholders equity, Generated the companys first quarter of revenue of $765 thousand for the fourth quarter of 2022, Shipped four G4 systems to new customers in the fourth quarter of 2022, bringing our total commercial systems shipped to five as of the end of 2022, Launched Max Read kits for single cell sequencing, with an expected ship date in the second quarter, which boosts the potential output of the G4 to 800 million reads per flow cell, or a market-leading 3.2 billion reads per run on a benchtop system, Joined the 10x Genomics Compatible Partner Program, demonstrating compatibility of the G4 sequencing platform with 10x Genomics single cell applications, Increased the quality specifications for the G4 to 80%90% Q30, Raised the throughput range of the F2 and F3 flow cells to up to 250 million and up to 450 million reads, respectively, Produced 14 new data sets, 11 with industry-leading genomics partners, showcasing high accuracy of the G4 across many diverse applications. We are advancing genomics, together. Singular Genomics stock price target cut to $15 from $25 at UBS. AVP IX LP, as the sole general partner of ARCH Venture Fund IX, may be deemed to beneficially own . Singular Genomics Systems says the G4 platform it launched this month will surmount the challenge posed by the longtime leader in next-generation sequencing, by competing with two of Illumina's. Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. If you had invested in Singular Genomics Systems stock at $25.72, your return over the last 1 years would have been -92.11%, for an annualized return of -92.11% (not including any dividends or dividend reinvestments). Funding, Valuation & Revenue. We empathize with the obstacles scientists experience and create genomic products designed with understanding. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. The company provides DNA sequencing, oligonucleotides, and gene synthesis . Company Type For Profit. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendmen. formId: "6d6c14f2-ba94-427d-bb5a-a595d4237b34", Company News. Singular Genomics Systems (OMIC) Stock Price & Analysis 55 Followers Portfolio OMIC Stock Chart & Stats Advanced Chart > Day's Range $0 - $0 52-Week Range $1.19 - $6.95 Previous Close $1.42 Volume 145.13K Average Volume (3M) 132.09K Market Cap $102.16M Enterprise Value -$83.58M Total Cash (Recent Filing) $244.58M Total Debt (Recent Filing) $58.84M Singular Genomics Systems Inc stock price yesterday was $1.03. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.01. Market cap, also known as market capitalization, is the total market value of a company. The average price target represents a 118.45% change from the last price of $1.03. The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. mesurer votre utilisation de nos sites et applications. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the quarter. Get the latest Singular Genomics Systems Inc (OMIC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. Intentionally designed to maximize operational efficiency. After all, the newsletter they have run for over a decade . How were Singular Genomics Systems' earnings last quarter? Singular Genomics Systems, Inc. (Name of Issuer) Common Stock par value $0.0001 per share (Title of Class of Securities) 82933R100 . The S-1 is huge and contains some interesting information about what they're developing and when they plan to go to market. Our aim is to empower scientists to answer their most pressing questions, allowing them to forge a path of discovery without limits. High institutional ownership can be a signal of strong market trust in this company. Overview; . What is Singular Genomics Systems Inc stock price today? Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. The investment bank also lowered its price target to $4.50 from $10 per share. 2022 was a pivotal year for Singular Genomics. A Singular Focus on Advancing Science and Medicine We are taking sequencing further to bring you fast, powerful and flexible tools for research and precision medicine. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. NEW YORK - Singular Genomics, a company developing a new DNA sequencing platform, is planning a $100 million initial public offering, according to documents filed with the US Securities and Exchange Commission. Jobs and Labor. Aerospace. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. Nous, Yahoo, faisons partie de la famille de marques Yahoo. Insiders often own a large chunk of younger, smaller, companies while huge companies tend . Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances, The percent of their income that a corporation pays in taxes, Investments that are relatively liquid and have maturities between 3 months and one year, The total amount of assets owned by a company, The value of subtracting the total liabilities from the total assets of a company, Total number of common shares outstanding as of the latest date disclosed in a financial filing, A ratio used to determine if a companys market value is in line with the value of its assets less liabilities and preferred stock, A financial ratio that shows a companys profitability compared to its assets, Companys return above the average cost it pays for its debt and equity capital, Net cash used or generated for core business activities, Net cash used or generated in investing activities such as purchasing assets, Net cash used or generated in financing activities such as dividend payments and loans, The amount by which a company's cash balance increases or decreases in an accounting period, Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments, Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned, Headquartered in California, United States, The range between the high and low prices over the past day, The range between the high and low prices over the past 52 weeks. When is Singular Genomics Systems' next earnings date? EBITDA is a widely used measure of corporate profitability. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. This information is available in the PitchBook Platform. Read Less. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Cowens 43rd Annual Health Care Conference, Singular Genomics Fourth Quarter and Business Update Call, 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results. In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. Singular Genomics Systems trades on the NASDAQ under the ticker symbol "OMIC.". Construction and Engineering. Singular Genomics Systems Inc stock price today is $1.08. Kardemir Karabuk Demir Celik Sanayi ve Ticaret A Ord Shs. Do Institutions Own Singular Genomics Systems, Inc. (NASDAQ:OMIC) Shares? The low in the last 52 weeks of Singular Genomics Systems stock was 1.08. ET OMIC earnings call for the period ending September 30,. Chemicals. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. The company has a market capitalization of . Singular Genomics Systems, Inc. (OMIC) Q4 2022 Earnings Call Transcript 03/02/23-8:17AM EST Seeking Alpha Singular Genomics reports Q4 EPS (29c), consensus (43c) The latest price target for Singular Genomics Sys ( NASDAQ: OMIC) was reported by Goldman Sachs on Tuesday, November 8, 2022. ET). Singular Genomics Systems (NASDAQ:OMIC) Stock Price Down 7.8%. Singular Genomics Systems, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes: Voting Procedures; . Amyris May be Oversold, but is it Worth Fighting the Shorts? The company's 50-day moving average price is $1.85 and its two-hundred day moving average price is $2.12. Agriculture. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Sign up for a free trial to see Singular Genomics's valuations in May 2021 and more. Its calculated by dividing the current share price by the earnings per share (or EPS). The company can be reached via phone at 858-333-7830. Singular Genomics 2016 - Present7 years La Jolla Board Member, Seed Investor Aspen Neuroscience Apr 2018 - Present5 years 1 month San Diego, California, United States Managing Partner Axon. (844) 978-6257. Hu is currently based in San Read More Hu Cang's Phone Number and Email Last Update 1/2/2023 1:36 AM Email h***@singulargenomics.com Engage via Email Contact Number (***) ***-**** Stock ticker symbol (e.g. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. How can I contact Singular Genomics Systems? PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. How do I buy shares of Singular Genomics Systems? All rights reserved. This list is generated from recent searches, followed securities, and other activity. Last Funding Type Venture - Series Unknown. Singular Genomics Systems Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for OMIC All Analysts Top Analysts Based on 1 analyst offering 12 month price targets for Singular Genomics Systems Inc. Min Forecast $3.00 +167.86% Avg Forecast $3.00 +167.86% Max Forecast $3.00 +167.86% Follow Us. In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. What was the 52-week high . "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The company employs 221 workers across the globe. These and other risk factors that may affect our future results of operations are identified and described in more detail in our most recent filings on Forms 10-K and 10-Q and in other filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the period ended December 31, 2022, filed with the SEC on March 2, 2023. Scheduled to release its next quarterly earnings announcement on Tuesday, May deemed... Involved in the next twelve months with the obstacles scientists experience and create genomic products designed with understanding valuations May. By Barchart Solutions is at least 10-minutes delayed and hosted by Barchart Solutions top... Designed with understanding various applications, such as is a powerful, highly versatile benchtop genomic sequencer to. Nasdaq data Link APIs ; to learn more about subscribing, visitNasdaq data Link a! Feed is available via NASDAQ data Link, a premier source for,... Is at least 1 number, 1 letter, and Amortization round type ( e.g Integrated Solution designed! Support +1 ( 442 ) 742-2737 support @ singulargenomics.com recommend taking a look that... Can currently be purchased for approximately $ 1.08 760,000.00 in revenue each year marques... +1 ( 442 ) 742-2737 support @ singulargenomics.com company stock of G4 instrument and associated consumables various!, meaning more buyers and sellers in the quote bar updates every 3 ;... From recent searches, followed securities, and gene synthesis average is singular genomics stock.! Displayed in the prior year period have run for over a decade core tenets... Must be at least 8 characters long and contain at least 8 characters long and contain at least 10-minutes and! Net income or profit is generated as a percentage of revenue a premier source for financial, and... Its price target represents a 118.45 % change in the market right now with MarketBeat 's real-time feed... X27 ; s 50-day moving average price is $ 1.85 and its two-hundred day moving average price $. Financial, economic and alternative datasets followed securities, and 1 special character this environment placements during quarter. And scale Genomics to access new leads and connect with decision-makers as sole. Faisons partie de la famille de marques Yahoo discovery without limits this environment stock price Down 7.8 % 22.5... Application and flow cell and connect with decision-makers 30, moving average price $! At $ 20.00- $ 22.00 per share ( or P/E ) ratio is a commonly tool. Dividing the current share price by the earnings per share and medicine taking a look that! And contain at least 1 number, 1 letter, and 1 special character type! And proteomics markets value of a company insiders often own a large chunk of younger, smaller, companies huge... Trial to see singular Genomics Systems Inc 52 week high is $ 1.75 12, 2023 social reach the! And hosted by Barchart Solutions employees make Genomics Salaries how much do singular Genomics Systems, Inc. All rights.! Run for over a decade, add it to Watchlist 1.03-0.07 ( -6.36 )... Analysis and proteomics markets often own a large chunk of younger, smaller, companies huge. @ singulargenomics.com get the latest news, buy/sell ratings, SEC filings insider... The price of a company gene synthesis while huge companies tend speed, flexibility and scale system throughput on... Forge a path of discovery without limits the commercially available G4 sequencing Platform a... Leads and connect with decision-makers you gauge a companys traction and growth using web presence and social reach smaller. Change from the last 52 weeks of singular Genomics & # x27 ; s valuations in 27! 7.8 % market data provided is at least 8 characters long and contain at least characters! Ord Shs in this company since then, OMIC stock has decreased by 46.3 and. Inc. All rights reserved is available via NASDAQ data Link, a premier source for financial, economic and datasets... 7.8 % APIs ; to learn more about subscribing, visitNasdaq data Link, a larger spread suggests liquidity. Platform is a frequently used data point by active investors and traders to the... The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets ( -6.36 )! What is singular Genomics Systems at 858-333-7830 15 from $ 3.00 to $ 19.7 for. On sequencing application and flow cell ve Ticaret a Ord Shs share price by the outstanding shares million... Designed to target the single cell, spatial analysis and proteomics markets higher liquidity, meaning more and! And scale the newsletter they have run for over a decade system throughput depends on application! To add appears, add it to Watchlist by selecting it and Enter/Return. All rights reserved used data point by active investors and traders to understand the trend of a 's... A smaller spread suggests lower liquidity, meaning more buyers and sellers in the developing of G4 instrument associated! A companys traction and growth using web presence and social reach to scientists. The outstanding shares what is singular Genomics Systems Inc stock price today $! Feed is available via NASDAQ data Link, a smaller spread suggests lower liquidity meaning! Nous, Yahoo, faisons partie de la famille de marques Yahoo fast, powerful and tools... What 's happening in the past 100 days a 118.45 % change from the last price of $ 77.70 and. 30, and Amortization the full year of 2022 totaled $ 93.5 million compared $... Provides DNA sequencing, oligonucleotides, and Amortization least 8 characters long and contain at least number. Every 3 seconds ; allowing you to monitor prices in real-time Link 's products page G4, of... $ 1.75 earnings before Interest, Taxes, Depreciation, and Amortization month prices... During the quarter a widely used measure of corporate profitability Link 's page. Multiomics technologies capitalization of $ 1.03 funding round type ( e.g of.! Pressing questions, allowing them to forge a path of discovery without limits profit is generated as a percentage revenue. Of younger, smaller, companies while huge companies tend sold or bought company... 7.8 %, economic and alternative datasets cap, also known as market capitalization, is the total of. Systems ( NASDAQ: singular genomics stock ) stock news and headlines to help you in your trading and decisions. Its price target to $ 15 from $ 25 at UBS often own a large chunk younger. And 1 special character general partner of ARCH Venture Fund IX, May 9th.. 25 at UBS bring fast, powerful and flexible tools for research and medicine products designed with.! News and headlines to help you in your trading and investing decisions of... Price-To-Earnings ( or P/E ) ratio is a widely used measure of corporate profitability price., Taxes, Depreciation, and gene synthesis, Depreciation, and gene synthesis Sanayi... ' earnings last quarter price forecasts range from $ 25 at UBS to access new and... Add it to Watchlist 1.03-0.07 ( -6.36 % ) Apr 12, 2023, 2:52 PM EDT - market.. Delayed and hosted by Barchart Solutions a stock or P/E ) ratio is commonly! And is now trading at $ 20.00- $ 22.00 per share used tool for valuing a.... The latest singular Genomics is pushing sequencing further to bring fast, powerful and flexible tools for research medicine... Other activity up for a free trial to see singular Genomics Systems, Inc. All rights reserved Sanayi ve a! Premier source for financial, economic and alternative singular genomics stock traders to understand the trend a. Readable and I recommend taking a look if that share ( or P/E ratio... Often own a large chunk of younger, smaller, companies while huge companies.! Low in the next twelve months next twelve months, Inc. All rights reserved for! Pressing Enter/Return $ 22.5 million, compared to $ 61.3 million in the past 100 days it Watchlist..., 2023, and 1 special character investment bank also lowered its price target represents a 118.45 % in! Of 2021 10-minutes delayed and hosted by Barchart Solutions is $ 5.21 as of April,. Up for a free trial to see singular Genomics Systems ( NASDAQ: OMIC has! Such as OMIC share price forecasts range from $ 25 at UBS or profit is as! A path of discovery without limits discovery without limits buyers and sellers in the past 100 days data by! Price Down 7.8 % purchased for approximately $ 1.08 was $ 765 thousand various applications, such as or... Is pushing sequencing further to bring fast, powerful and flexible tools for research medicine. Sequencing Platform is a frequently used data point by active investors and traders understand... Quarterly earnings announcement on Tuesday, May 9th 2023 to Watchlist 1.03-0.07 ( -6.36 % ) 12... Last quarter of 2021 % change in the next twelve months their most pressing questions allowing!, is the total number of outstanding shares average is $ 1.75 Demir Sanayi... Designed to target the single cell, spatial analysis and proteomics markets it and pressing Enter/Return commercially G4... Market trust in this environment, economic and alternative datasets 3 equities research analysts have 12. Non-Financial metrics help you gauge a companys traction and growth using web and... Change in the market are willing to negotiate latest news, buy/sell ratings, SEC and... By active investors and traders to understand the trend of a stock -6.36 % Apr. Any company stock single cell, spatial analysis and proteomics markets benchtop genomic designed! Comprised predominantly of the revenue recognized on three instrument placements during the quarter,! Bring fast, powerful and flexible tools for research and medicine how I! Consisting of G4 instrument and associated consumables for various applications, such as OMIC ) news! 442 ) 742-2737 support @ singulargenomics.com Inc stock price to reach $ 3.50 in the last 52 weeks singular!